Andrew Bate

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Drug safety

Pharmacoepidemiology and drug safety

Pharmaceutical statistics

Nature reviews. Drug discovery

Pfizer Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Ltd Sep 01 2011

United Kingdom

Epidemiology Group Lead, Analytics :: Epidemiology

Publications

Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety (2024)
Vicki Osborne, Amie J Goodin, Joshua Brown, Almut G Winterstein, Andrew Bate, Catherine Cohet, Lisa G Pont, David Moeny, Olaf Klungel, Simone Pinheiro, John D Seeger, K Arnold Chan, Stanley Edlavitch, Hugh Tilson, Deborah Layton
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and drug safety 33 (4) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
François Haguinet, Andrew Bate, Jens-Ulrich Stegmann
The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs. Pharmacoepidemiology and drug safety (2023)
Jens-Ulrich Stegmann, Rory Littlebury, Markus Trengove, Lea Goetz, Andrew Bate, Kim M Branson
Trustworthy AI for safe medicines. Nature reviews. Drug discovery (2023)
Oeystein Kjoersvik, Andrew Bate
Black Swan Events and Intelligent Automation for Routine Safety Surveillance. Drug safety 45 (5) (2022)
Andrew Bate, Yuan Luo
Artificial Intelligence and Machine Learning for Safe Medicines. Drug safety 45 (5) (2022)
Nicolle M Gatto, Shirley V Wang, William Murk, Pattra Mattox, M Alan Brookhart, Andrew Bate, Sebastian G Schneeweiss, Jeremy A Rassen
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiology and drug safety 31 (11) (2022)
Astrid Coste, Angel Wong, Marleen Bokern, Andrew Bate, Ian J Douglas
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review. Pharmacoepidemiology and drug safety (2022)
Andrew Bate, Steve F Hobbiger
Artificial Intelligence, Real-World Automation and the Safety of Medicines. Drug safety 44 (2) (2020)
Rachel E Sobel, William Blackwell, David M Fram, Andrew Bate
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool. Drug safety 42 (11) (2020)
Jesper Hallas, Olaf Klungel, Almut Winterstein, Krista F Huybrechts, Nina Sahlertz Kristiansen, Sebastian Schneeweiss, Stephen Evans, Andrew Bate, Lisa Pont, Gianluca Trifirò, Meredith Smith, Alison Bourke
The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force. Pharmacoepidemiology and drug safety 28 (12) (2019)
Andrew Bate
Guidance to reinforce the credibility of health care database studies and ensure their appropriate impact. Pharmacoepidemiology and drug safety 26 (9) (2019)
Andrew Bate, Ken Hornbuckle, Juhaeri Juhaeri, Stephen P Motsko, Robert F Reynolds
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance. Therapeutic advances in drug safety 10 (2019)
Andrew Bate, Christy Chuang-Stein, Andrew Roddam, Byron Jones
Lessons from meta-analyses of randomized clinical trials for analysis of distributed networks of observational databases. Pharmaceutical statistics 18 (1) (2018)
Rachel E Sobel, Andrew Bate, Robert F Reynolds
Real World Evidence: Time for a Switch? Drug safety 41 (12) (2018)
Rachel E Sobel, Andrew Bate, James Marshall, Kevin Haynes, Nandini Selvam, Vinit Nair, Gregory Daniel, Jeffrey S Brown, Robert F Reynolds
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools. Pharmacoepidemiology and drug safety 27 (3) (2018)
Andrew Bate, Jürgen Beckmann, Alexander Dodoo, Linda Härmark, Kenneth Hartigan-Go, Anna Hegerius, Marie Lindquist, Eugène van Puijenbroek, Marco Tuccori, Ulrich Hagemann
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery. Drug safety 40 (3) (2017)

Andrew Bate.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew Bate